• bitcoinBitcoin(BTC)$65,211.000.28%
  • ethereumEthereum(ETH)$1,824.680.04%
  • tetherTether(USDT)$1.00-0.02%
  • binancecoinBNB(BNB)$592.20-0.34%
  • usd-coinUSDC(USDC)$1.00-0.01%
  • rippleXRP(XRP)$0.96-1.64%
  • solanaSolana(SOL)$71.62-0.84%
  • tronTRON(TRX)$0.3052430.05%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.050.00%
  • HyperliquidHyperliquid(HYPE)$70.433.80%
  • zcashZcash(ZEC)$908.360.44%
  • moneroMonero(XMR)$494.18-0.03%
  • dogecoinDogecoin(DOGE)$0.059032-0.64%
  • leo-tokenLEO Token(LEO)$9.210.33%
  • USDSUSDS(USDS)$1.000.01%
  • whitebitWhiteBIT Coin(WBT)$62.990.11%
  • chainlinkChainlink(LINK)$9.13-1.29%
  • cardanoCardano(ADA)$0.153034-0.91%
  • stellarStellar(XLM)$0.137656-2.31%
  • Ethena USDeEthena USDe(USDE)$1.00-0.03%
  • daiDai(DAI)$1.000.02%
  • bitcoin-cashBitcoin Cash(BCH)$208.94-0.52%
  • RainRain(RAIN)$0.00587169.00%
  • nearNEAR Protocol(NEAR)$3.17-0.79%
  • litecoinLitecoin(LTC)$44.53-1.71%
  • CantonCanton(CC)$0.082484-2.65%
  • avalanche-2Avalanche(AVAX)$7.12-1.81%
  • uniswapUniswap(UNI)$5.150.03%
  • tether-goldTether Gold(XAUT)$3,839.43-0.59%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.05-1.35%
  • USD1USD1(USD1)$1.00-0.01%
  • suiSui(SUI)$0.72-1.76%
  • Ripple USDRipple USD(RLUSD)$1.000.01%
  • Global DollarGlobal Dollar(USDG)$1.000.01%
  • hedera-hashgraphHedera(HBAR)$0.057413-2.51%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.15-0.14%
  • paypal-usdPayPal USD(PYUSD)$1.000.01%
  • shiba-inuShiba Inu(SHIB)$0.000004-1.76%
  • crypto-com-chainCronos(CRO)$0.0434401.45%
  • BittensorBittensor(TAO)$191.78-0.87%
  • quant-networkQuant(QNT)$153.38-2.06%
  • Circle USYCCircle USYC(USYC)$1.140.00%
  • Spiko Amundi Overnight Swap Fund (EUR)Spiko Amundi Overnight Swap Fund (EUR)(EURSAFO)$1.12-0.20%
  • MemeCoreMemeCore(M)$0.852.50%
  • okbOKB(OKB)$86.01-2.84%
  • pax-goldPAX Gold(PAXG)$3,841.96-0.61%
  • aaveAave(AAVE)$107.91-0.64%
  • Falcon USDFalcon USD(USDF)$1.000.01%
  • pepePepe(PEPE)$0.0000041.30%
  • United StablesUnited Stables(U)$1.00-0.02%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Biopharmaceutical Giant Celgene Purchases Receptos for $7.2B in Cash —-NEED CHANGE

July 3, 2023
in Trade Tube
Reading Time: 1 min read
A A
ShareShareShareShareShare



Celgene (CELG) announced late on Tuesday that it had acquired San Diego-based Receptos (RCPT) for $7.2 billion in cash. Under the terms of the purchase, Summit, N.J.-based Celgene will pay $232 a share in cash for Receptos, up nearly 12% from the target’s $207.18 closing price Tuesday. In paying a premium for Receptos, Celgene aims to enhance its inflammation and immunology portfolio, with hopes that it will diversify revenue and accelerate growth beginning in 2019. Along with the purchase of Receptos, Celgene will gain its Phase 3 inflammatory bowel disease and multiple sclerosis drug, Ozanimod. The oral drug is expected to build upon Celgene’s growing expertise in inflammatory bowel disease. Celgene will acquire all outstanding shares of common stock in Receptos through a tender offer, followed by a second-step merger.

Subscribe to TheStreetTV on YouTube:

YOU MAY ALSO LIKE

Nvidia before earnings: Buy or wait? AI trade: Healthy reset or deeper trouble? Nvidia or Broadcom?

Bull Market ‘Has Room to Run’: 10 Stocks to Buy Now

For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:

source

ShareTweetSendSharePin

Related Posts

Nvidia before earnings: Buy or wait? AI trade: Healthy reset or deeper trouble? Nvidia or Broadcom?
Trade Tube

Nvidia before earnings: Buy or wait? AI trade: Healthy reset or deeper trouble? Nvidia or Broadcom?

November 16, 2026
Bull Market ‘Has Room to Run’: 10 Stocks to Buy Now
Trade Tube

Bull Market ‘Has Room to Run’: 10 Stocks to Buy Now

November 16, 2026
I Scalped 00 In the Blink of an Eye
Trade Tube

I Scalped $1800 In the Blink of an Eye

November 16, 2026
The Pitfalls of Rivalry: Social Comparisons (With Nir Halevy)
Trade Tube

The Pitfalls of Rivalry: Social Comparisons (With Nir Halevy)

November 16, 2026
Next Post
Will Disney be Able to Attract Chinese Consumers to Its New Theme Park?

Will Disney be Able to Attract Chinese Consumers to Its New Theme Park?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Adam Hamilton gives victory speech after historic Kansas win

Adam Hamilton gives victory speech after historic Kansas win

November 10, 2026
“Manosphere” that helped Trump could be rethinking

“Manosphere” that helped Trump could be rethinking

November 14, 2026
Google’s Gemini Targets Health Care’s Data Problem

Google’s Gemini Targets Health Care’s Data Problem

November 11, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!